# A Comparison of Two Treatments: Pacemaker and Percutaneous Transluminal Septal Ablation for Hypertrophic Cardiomyopathy

> **NCT00001894** · PHASE2 · COMPLETED · sponsor: **National Heart, Lung, and Blood Institute (NHLBI)** · enrollment: 70 (—)

## Conditions studied

- Hypertrophic Cardiomyopathy

## Interventions

- **PROCEDURE:** pacemaker implantation
- **PROCEDURE:** percutaneous transluminal septal ablation (PTSA)

## Key facts

- **NCT ID:** NCT00001894
- **Lead sponsor:** National Heart, Lung, and Blood Institute (NHLBI)
- **Sponsor class:** NIH
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 1999-08
- **Primary completion:** —
- **Final completion:** 2002-09
- **Target enrollment:** 70 (—)
- **Last updated:** 2006-07-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00001894

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00001894, "A Comparison of Two Treatments: Pacemaker and Percutaneous Transluminal Septal Ablation for Hypertrophic Cardiomyopathy". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00001894. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*